Description

Hypnofast is a short-acting sedative prescribed for rapid sleep induction and calming prior to medical or diagnostic procedures. It provides anxiolytic, anticonvulsant, and muscle-relaxant effects. Due to its potency and dependence risk, use is strictly limited to short treatment periods under medical supervision.

How It Works

Midazolam works by binding to gamma-aminobutyric acid type A (GABA-A) receptors in the brain, enhancing inhibitory neurotransmission. This action suppresses excessive neural activity associated with anxiety, insomnia, and agitation. The calming and sedative effects appear rapidly after administration.

Dosage

Typical adult oral doses of Hypnofast range between 7.5 mg and 15 mg. Lower doses are recommended for elderly patients or individuals with underlying medical conditions.

Injectable dosing is individualized and must be administered under strict medical supervision, particularly in hospital or procedural settings.

Side Effects

Common side effects may include:

• Sedation and reduced alertness
• Impaired coordination
• Confusion or forgetfulness

Although rare, respiratory depression is a serious potential risk, especially at higher doses or when combined with other sedatives.

Pregnancy & Breastfeeding

Hypnofast is not routinely recommended during pregnancy due to potential risks to the developing fetus. Use should only occur if the expected benefit clearly outweighs the risk.

Midazolam may be excreted in breast milk and could affect infants. Medical advice is essential before use while breastfeeding.

Storage

Store Hypnofast in its original packaging at room temperature. Protect from humidity and excessive heat. Always keep the medication out of reach of children.

UK Regulation

Hypnofast is available in the UK only with a valid prescription. It is regulated under benzodiazepine safety guidelines due to its potential for dependence and misuse. Ongoing monitoring may be required during treatment.